Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FK43E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,366
Award facts
- Contract value 100% obligated
- $18,365.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,365.86 to AmerisourceBergen Drug Corp for the supply of Vraylar 3 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026.
Vraylar is a brand-name antipsychotic medication used in the treatment of psychiatric conditions. This delivery order exemplifies the ongoing pharmaceutical supply chain support that AmerisourceBergen provides to the Defense Health Agency and other federal healthcare customers through its comprehensive prime vendor agreement. The firm's federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements, ranging from specialty medications and generic drugs to vaccines and medical devices, supporting military healthcare operations globally. AmerisourceBergen's continued selection for such orders reflects its competitive positioning within the federal pharmaceutical procurement landscape and its role as a critical vendor for defense medical logistics.
Quick answers
Who was awarded contract SPE2DB25FK43E?
SPE2DB25FK43E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FK43E worth?
The government has obligated $18,366 on SPE2DB25FK43E.
Is contract SPE2DB25FK43E an order under another contract?
Yes. SPE2DB25FK43E is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK43E competed?
The extent of competition for SPE2DB25FK43E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award